#United States #Brentwood #government shutdown #CONTRAVE #Currax Pharmaceuticals

Currax Pharmaceuticals Provides Free Access to CONTRAVE®

In light of the current government shutdown, Currax Pharmaceuticals LLC is stepping in to offer its prescription weight-loss medication, CONTRAVE® (naltrexone HCl/bupropion HCl), free of charge to federal employees enrolled in the Federal Employee and Retirees Health Plan (FEP). This initiative underscores Currax's commitment to ensuring that patients can access crucial medications without facing undue financial burdens during challenging times.

Currax Pharmaceuticals, which has established itself as a key player in the pharmaceutical landscape, is dedicated to providing innovative solutions for chronic health issues. Since acquiring CONTRAVE®, the leading oral weight-loss medication in the U.S., the company has made significant strides in enhancing patient outreach and education, as well as broadening access to treatment options.

The introduction of the CurAccess™ Program five years ago highlights Currax's mission to alleviate out-of-pocket expenses for patients. This program has consistently maintained the same cost for cash-paying patients since 2019, reflecting the company’s commitment to patient affordability. With the recent announcement, Currax is not only reinforcing its affordability initiative but also extending a helping hand to federal employees facing the additional stressors brought on by the government shutdown.

George Hampton, President and CEO of Currax Pharmaceuticals, expressed the company’s gratitude toward federal employees: "As an American company, we value the service of our federal employees. Providing free medication to FEP beneficiaries during the shutdown is one way we can support these families during a challenging time."

The Impact of the Government Shutdown

The ongoing governmental gridlock continues to pose significant obstacles for numerous workers, many of whom are left without stable wages and the benefits they rely on for their health care. In light of this situation, Currax’s initiative comes as a critical relief for those affected, ensuring they can maintain their health regimens without the added burden of prescription costs.

CONTRAVE is specifically designed for adults with obesity or overweight individuals dealing with weight-related medical problems, helping them achieve and maintain weight loss in conjunction with a reduced-calorie diet and increased physical activity. However, it’s crucial to note that the prescription is not approved for use in individuals under eighteen, and its administration requires careful consideration of potential side effects and contraindications, including serious risks of suicidal thoughts due to one of its components, bupropion.

Patients are encouraged to keep a close eye on their mental health while using the medication and to consult healthcare providers regarding its use, particularly if they have previous histories of mental illness or other relevant conditions.

Access and Further Information

For those interested in accessing CONTRAVE during this period, relevant details can be found at www.contrave.com or www.getcontravenow.com.

Currax Pharmaceuticals not only targets obesity but also works diligently against smoking in an effort to tackle the leading causes of preventable deaths in the U.S. The company’s portfolio includes various branded and generic products aimed at improving patient well-being, showcasing their commitment to public health.

In summary, Currax Pharmaceuticals' decision to provide CONTRAVE® at no cost sheds light on the essential role of pharmaceutical companies in ensuring patient access to necessary treatments during times of uncertainty. This initiative not only alleviates financial stress but also enhances overall health outcomes for affected individuals, emphasizing the importance of corporate responsibility in public health.

Safety Information

Patients considering CONTRAVE should be aware of crucial safety information, including potential side effects, such as nausea, headaches, and the risk of seizures, particularly when taken alongside certain other medications. It is essential to engage with healthcare providers to discuss any concerns, pre-existing conditions, or additional medications being taken.

For further inquiries or detailed information about CONTRAVE, patients and their families can connect with medical professionals or reach out directly to Currax Pharmaceuticals for more comprehensive support and guidance.